RecruitingPhase 4NCT07277257

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

Evaluating TRYPTYR as a Novel Therapy for Dry Eye in Patients With Sjögren's Syndrome

Sponsor

Center For Sight

Enrollment

35 participants

Start Date

Dec 2, 2025

Study Type

INTERVENTIONAL

Conditions

Sjogren Syndrome With Keratoconjunctivitis

Summary

This study will evaluate the effect of TRYPTYR in patients with Sjögren's syndrome-related dry eye disease. The goal is to determine whether TRYPTYR can improve symptoms and signs of dry eye in this specific patient population.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called TRYPTYR (Acoltremon ophthalmic solution 0.003%) for people with sjogren syndrome with keratoconjunctivitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTRYPTYR (Acoltremon ophthalmic solution 0.003%)

Drop to be instilled before and after endpoint measurement.

Locations(1)

Center For Sight

Venice, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07277257